Please find the attached outcome of the Extra Ordinary General Meeting.
Awaiting price reaction for this filing.
Raymed Labs Limited (Scrip Code: 531207, referred to in the headline as Cresanto Global Ltd, which appears to be the proposed new name) held an Extra Ordinary General Meeting on April 21, 2025, from 12:30 PM to 01:00 PM at its Goregaon East, Mumbai corporate office. Four directors, the CFO, Company Secretary, and 5 members were present; quorum was confirmed. All 11 resolutions on the agenda were passed by the requisite majority through remote e-voting (NSDL platform, April 17-21, 2025) and ballot papers at the meeting. Key resolutions approved include: change of company name (with MOA/AOA amendment), alteration of main objects clause, shifting of registered office from Uttar Pradesh to Maharashtra, appointment of Mr. Prashant Bajaj as Managing Director, regularisation of four additional directors (Nishant Bajaj, Urmila Sharma, Vipul Dubey, Prity Bishwakarma), loans/investments/guarantees under Section 185, and approval of material related party transactions.
Shareholders should note significant corporate restructuring: a potential name change to 'Cresanto Global Ltd', relocation of registered office from UP to Maharashtra, elevation of Prashant Bajaj to Managing Director, and approval of material related party transactions. These changes signal a strategic repositioning that could affect the company's identity, governance structure, and disclosed financial relationships.